TRIUS THERAPEUTICS INC has a total of 39 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIOKINESIS, FUJIYAKUHIN CO LTD and OKAPI SCIENCES NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | China | 4 | |
#4 | Canada | 3 | |
#5 | Mexico | 3 | |
#6 | South Africa | 3 | |
#7 | Argentina | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Hong Kong | 1 | |
#12 | Japan | 1 | |
#13 | New Zealand | 1 | |
#14 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds | |
#5 | Climate change adaptation technologies | |
#6 | Microorganisms | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Finn John | 19 |
#2 | Duguid Robert J | 14 |
#3 | Trzoss Michael | 14 |
#4 | Chen Zhiyong | 14 |
#5 | Li Xiaoming | 14 |
#6 | Bensen Daniel | 14 |
#7 | Zhang Junhu | 14 |
#8 | Tari Leslie William | 12 |
#9 | Nguyen Toan B | 11 |
#10 | Wong Sergio E | 11 |
Publication | Filing date | Title |
---|---|---|
WO2015054246A1 | Methods of treating subjects with renal impairment using tedizolid | |
EP2895488A1 | Tricyclic gyrase inhibitors for use as antibacterial agents | |
US2013102523A1 | Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use | |
TW201245200A | Tricyclic gyrase inhibitors | |
WO2011032050A2 | Gyrase inhibitors | |
US2007178111A1 | Identification and application of antibiotic synergy | |
US2007218481A1 | Method for identifying drug-sensitizing antisense DNA fragments and use thereof |